Skip to main navigation
Healthcare Providers in the U.S. can now  begin prescribing AspyreRx
logo
  • Overview
  • News & Events
    • Press Releases
    • Presentations & Events
  • Stock
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Governance
    • Documents & Charters
    • Board of Directors
    • Leadership
    • Committee Composition
    • Financial Concern Hotline
    • Code of Conduct Hotline
  • Financials
    • SEC Filings
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact

Event Details

Better Therapeutics Third Quarter 2022 Business Update Call

Nov 14, 2022 | 4:30 PM EST

Click here for recording

Supporting Materials

Better Therapeutics Q3 2022 Earnings 737.6 KB
Better therapeutics black bg - no clear space

Investor Relations

News & Events Press Releases Presentations & Events
Stock Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
Governance Documents & Charters Board of Directors Leadership Committee Composition Financial Concern Hotline Code of Conduct Hotline
Financials SEC Filings
Investor Resources Investor FAQs Email Alerts Contact
© Better Therapeutics, Inc       

Footer Terms Policy Links

Terms      Privacy     

Footer Social Links

Facebook Instagram LinkedIn Twitter
x
Exit

You are leaving Better Therapeutics, Inc. website. You may return to Better Therapeutics, Inc. website by using the back button on your web browser toolbar or closing the window to the third-party website that you have opened. Do you wish to continue?

YES NO